Editor’s note: This continues Jack Dunigan’s series about unsung heroes in the workplace, and the 16 traits they all share.

Too often when corrective action is taken, the communication loop is not closed, turning containment into a frustrating, permanent practice.

Editor’s note: Denise Robitaille is a member of the U.S. TAG to ISO/TC 176, the committee responsible for updating the ISO 9000 family of standards. She will be reporting on the revision progress to ISO 9001, which will be completed in 2015.

I’m in the middle of a hot, humid stretch of weather, as are many of the U.S. readers. I can hardly think straight, so I’ve decided to lighten things up a bit today.

Editor's note: This is the first in a five-part series exploring issues that affect management’s ability to detect the warning signals of current good manufacturing practice (cGMP) compliance problems in the pharmaceutical industry.

New products and new processes do not appear full-grown. They are founded on new principles, which in turn are painstakingly developed by research in the realms of science.

—Vannevar Bush